Skip to main content
Fig. 2 | BMC Cancer

Fig. 2

From: Exercise training and NR supplementation to improve muscle mass and fitness in adolescent and young adult hematopoietic cell transplant survivors: a randomized controlled trial {1}

Fig. 2

Overview of the study scheme. During their baseline visit, participants will be randomized into either exercise or non-exercise group and either NR supplementation or placebo. After randomization, participants who were randomized into exercise group will receive their equipment and be oriented to the in-home exercise intervention. Participants who were randomized into NR group will receive NR daily at a dose based on body weight: 300 mg for individuals with weight 24 to < 48 kg, 600 mg for those with weight 48 to < 72 kg, and 900 mg for those with weight 72 kg or greater. After 8 weeks (\(\pm 1.5\) weeks), all the participants will have their interim visit. After 16 weeks from the baseline visit, participants will have their final study visit. The figure was generated using Microsoft PowerPoint (Version 16.62)

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us